This quarterly update report highlights recent trends in the pharmaceutical industry, focusing on AI-related deals, talent acquisition, and patent filings.
Pharmaceutical companies are leveraging AI through recent patents covering applications like automated cell positioning, prime editing efficiency prediction, respiratory disease prevention, predictive modeling for cell culture, and disinfection methods.
Despite a 32% decline in AI-related patent applications in Q3 2023, the industry is strategically investing in AI, with a 14% growth in AI-related deals compared to Q3 2022. Job postings in the pharmaceutical industry saw a 38% drop in Q3 2023, with top AI-related roles in computer and mathematical occupations and management. Major companies like Johnson & Johnson and Bristol-Myers Squibb are leading in AI hiring. The US is at the forefront of AI adoption in the pharmaceutical industry, while the UK, China, South Korea, and Canada also play significant roles. Overall, this indicates a transformative shift in the pharmaceutical industry, with a focus on AI innovation, strategic deals, and talent acquisition. The full report can be purchased.
